Načítá se...
Review of the COVID-19 Risk in Multiple Sclerosis
The ongoing pandemic of the novel coronavirus of 2019 (COVID-19) has resulted in over 1 million deaths, primarily affecting older patients with chronic ailments. Multiple sclerosis (MS) patients have been deemed particularly vulnerable given their high rates of disability and increased susceptibilit...
Uloženo v:
| Vydáno v: | J Cell Immunol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8098748/ https://ncbi.nlm.nih.gov/pubmed/33959727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.33696/immunology.3.080 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|